103. Mechanism of action drug A. Proprotein convertase subtilisin/kexin9inhibitors B. hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors C. Lipoprotein...

Transcribed Image Text:

103. Mechanism of action drug A. Proprotein convertase subtilisin/kexin9inhibitors B. hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors C. Lipoprotein lipase activator D. Microsomal triglyceride transport inhibitor a. A.4, B.3, C.1, D.2 b. A.3, B.1, C.4, D.2 c. A.4, B.1, C.2, D.3 d. A.2, B.3, C.4, D.1 1. fenofibrate 2. lomitapide 3. pravastatin 4. alirocumab 103. Mechanism of action drug A. Proprotein convertase subtilisin/kexin9inhibitors B. hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors C. Lipoprotein lipase activator D. Microsomal triglyceride transport inhibitor a. A.4, B.3, C.1, D.2 b. A.3, B.1, C.4, D.2 c. A.4, B.1, C.2, D.3 d. A.2, B.3, C.4, D.1 1. fenofibrate 2. lomitapide 3. pravastatin 4. alirocumab